Professional Documents
Culture Documents
November 2018
Loblaw
L Compani TSX Food- $12,258.00 $52.90 $61.29 15.86% $1678.00
es Ltd. Retail
Retail-
BBY Best Buy NYSE Consum $4,426.35 $72.99 $64.15 (12.11%) ($609.96)
Inc. er
Internati Paper
IP onal NYSE and $4,942.33 $46.48 $46.19 (0.62%) ($31.03)
Papers Related
Products
Floor &
FND Decor NYSE Consum $6,626.00 $32.93 $33.13 0.61% $40.00
Holdings er
S&P 500
SPY ETF NYSE ETF $38,596.60 $280.48 $275.69 (1.71%) ($670.60)
Cash $33,557.13
###
was the largest of its kind since 2016.
Despite beating earnings after we entered this position, Best Buy’s stock has received negativity due
to the uncertain retail environment and increased competition in the e-commerce business from
Amazon. Going forward, it is important to note that Amazon alone cannot fill the demand of the
consumer electronics sector. With 18% higher Black Friday foot traffic, Best Buy is signalling a bullish
case. Our position in International Papers (NYSE: IP) has not experienced much volatility, sitting at a
0.62% loss for the month. We also have a large position in the S&P 500 ETF (NYSE: SPY) and a small
position in Floor and Decor Holdings (NYSE:FND) which have been stagnant.
Closed Positions
Company Market Entry
Symbol Exchange Sector Exit Price P/L % P/L $
Name Value Price
Arrowhe Medical
ad -
ARWR Pharmac NASDAQ Biomedi $2,770.00 $14.61 $13.85 (5.20%) ($76.00)
enticals cal
Genetics
On the other hand, we exited our position in Arrowhead Pharmaceuticals (NASDAQ:ARWR) during this
month. The reason for the exit was that a stop-loss was triggered. This position intended to profit
from Arrowhead’s announcement on its liver medication trial results. The trial was successful as
expected; however, due to the timing of the trial in the midst of market corrections and panicked
investors, the stock saw a temporary decline. Going into this trade, our investments team was firm on
a 5% stop loss to ensure a proper risk management protocol. Due to the risks involved in this trading
strategy, we only dedicated 3% of our portfolio into this trade, and therefore have successfully
generated alpha for the month of November.
Loblaw
L Companies TSX Food - Retail $12,258.00 $52.90 12.21%
Ltd.
Paper and
IP International NYSE related $4,942.33 $46.48 4.92%
Papers products
Arrowhead Medical -
ARWR Pharmacenti NASDAQ Biomedical $2,770.00 $14.61 2.76%
cals Genetics
Floor &
FND Decor NYSE Consumer $6,626.00 $32.93 6.60%
Holdings
November being our equity fund’s first month of trading, we opened several new positions
throughout the month. After a downtrend throughout October in the stock price of Loblaw
Companies Ltd. (TSE:L), we decided to open a long position in the retail giant. We simply believe that
the market had an overreaction over Loblaw’s failed attempt to spin off its Choice Properties REIT
followed by an analyst downgrade. Further, we opened a long position in Arrowhead Pharmaceuticals
(NASDAQ:ARWR). We carefully analyzed pending patents of ARWR under careful review from the FDA
which were due for announcements in late November. As mentioned earlier, this position has been
closed. Our associate team also pitched several other investment ideas including Best Buy Co.
(NYSE:BBY), International Papers (NYSE:IP) and Floor and Decor Holdings (FND) which were added to
the portfolio.
Disclaimer: all information present in this report is for educational and informational purpose only and without warranty of any kind. All
information present in this report represents only the opinion of the writers, which may be influenced by various factors. You are advised to
conduct your independent research and invest responsibly. Investing in markets may not be suitable for all investors, and investing in the
stock market has risks, with the possibility in which you could lose all your investment. Before making your investment decision, please
consult with your financial advisor. York Trading Club is not responsible for your losses, financial or otherwise, as a result of making
investment decisions.
Charts produced with TradingView. York Trading Club © 2018, All Rights Reserved.